ClinicalTrials.gg
RecruitingNCT06497816Updated Jun 25, 2026

Health Literacy, Physical and Cognitive Function, Health-related Behaviors, and Quality of Life in COPD

An observational study in COPD, Health Literacy and Health-Related Behavior, sponsored by Hacettepe University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 40 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-25.

Sponsored by Hacettepe University · Observational

How we know

From the registry’s dates

  • Started Jun 2024; still recruiting 2 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
144
Ages
40 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 18 studies in Pulmonary Disease, Chronic Obstructive by Hacettepe University — 10 open to participants now, 12 under way, none of them phase 3. Pulmonary Disease, Chronic Obstructive · Hacettepe University.

Planned enrollment
Largest of 12
144 · median 45
Started
2024
with 6 others
Observational
12 of 18
8 open now
Primary completion
2027-06
later than 10 of 11 live
Registered
10th of 18
by date

Among the 18 studies in Pulmonary Disease, Chronic Obstructive by Hacettepe University, this one has the largest planned enrollment of the 12 observational ones that give a count, is one of 7 that started in 2024, is one of 12 observational ones, reaches primary completion later than 10 of the 11 other live ones, and was the 10th registered.

Pulmonary Disease, Chronic Obstructive

5,529 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 858 are open to participants now.

Browse Pulmonary Disease, Chronic Obstructive studies →

Open to participants now

10 of the 18 studies in Pulmonary Disease, Chronic Obstructive by Hacettepe University are open now, in 1 country. Recruiting first, the newest first:

4 more — sign in →

By country, each count listing its studies:

All 10 open studies →

Where they have run

Who these studies take

Of the 560 Pulmonary Disease, Chronic Obstructive studies recruiting now, 307 (55%) set no upper age limit and 82 (15%) stop at 75 or younger; 30 take children under 18; 88 take healthy volunteers.

This study: 40 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Pulmonary Disease, Chronic Obstructive by Hacettepe University, or all of them as a file.
02

Study summary

Health literacy is important for controlling disease progression and living a healthy life with illness. High health literacy is associated with higher cognitive performance and lower health-related quality of life. Physical, psychological, and social impairments are seen in chronic obstructive pulmonary disease (COPD). Studies investigating the relationship between health literacy and functional capacity, quality of life, physical activity, cognitive function, health-related behavior, and activities of daily living in individuals with COPD are limited. Therefore, the aim of this study was to compare individuals with COPD with healthy individuals in terms of health literacy, functional capacity, quality of life, physical activity, cognitive function, health-related behavior, and activities of daily living and to investigate the relationship between health literacy and functional capacity, quality of life, physical activity, cognitive function, health-related behavior, and activities of daily living in individuals with COPD.

03

Conditions studied

  • COPD
  • Health Literacy
  • Health-Related Behavior
04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Individuals with COPD and Healthy Controls

Eligibility criteria

Inclusion criteria for the group:

  • Being over 40 years old,
  • Diagnosed with COPD and being clinically stable,
  • Being able to cooperate with the tests to be performed,
  • Not having any cardiovascular disease, orthopedic or neurological problems that may affect the tests,
  • Being willing to participate in the study.

Exclusion criteria for the COPD group:

  • Being in an acute exacerbation period,
  • Having any cardiovascular disease, orthopedic or neurological problems that may affect the tests,
  • Not being willing to participate in the study.

Inclusion criteria for the control group:

  • Being willing to participate in the study and being over 40 years old
  • Not having any known disease

Exclusion criteria for the control group:

  • Not being able to cooperate with the tests to be performed
  • Not being willing to participate in the study
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
144 participants (estimated)
Patient registry
No

Groups and cohorts

  • COPD

    Individuals with stable COPD

    Other: No intervention

  • Healthy Individuals

    Healthy controls

    Other: No intervention

Interventions

  • OtherNo intervention

    No intervention

06

What researchers measure

Primary outcomes

  1. Functional capacity

    Functional capacity assessment using self-paced 6-minute walk test.

    Time frame: 1st day

  2. Health literacy

    Test of Functional Health Literacy in Adults will be used to evaluate health literacy. The TOFHLA is scored on a scale of 0 to 100 and higher scores indicate higher health literacy.

    Time frame: 1st day

  3. Health literacy

    The Rapid Estimate of Adult Literacy in Medicine questionnaires will be performed. A score of 59 or less is defined as indicating low health literacy and a score of 60 or more indicates adequate health literacy.

    Time frame: 1st day

  4. Cognitive function

    Montreal Cognitive Assessment will be used to evaluate cognitive function. The Montreal Cognitive Assessment scores range between 0 and 30. A score of 26 or over is considered to be normal.

    Time frame: 1st day

  5. Health-related behavior

    Health-related Behavior Scale II will be performed to assess health-related behavior. The Health-related Behavior Scale II measures various health-related behaviors and is designed to assess the frequency or extent of engagement in these behaviors. Higher scores of the scale indicate more frequent or healthier behaviors, depending on the specific behavior being measured.

    Time frame: 1st day

  6. Functional exercise capacity

    One-minute sit to stand test will be performed. The number of repetitions will be recorded.

    Time frame: 1st day

Secondary outcomes

  1. Forced vital capacity

    Pulmonary function test using a spirometer will be performed. Forced vital capacity will be recorded.

    Time frame: 1st day

  2. Forced expiratory volume in one second

    Pulmonary function test using a spirometer will be performed. Forced expiratory volume in one second will be recorded.

    Time frame: 1st day

  3. forced expiratory volume in one second/forced vital capacity ratio

    Pulmonary function test using a spirometer will be performed. Forced expiratory volume in one second/forced vital capacity ratio will be recorded.

    Time frame: 1st day

  4. Peak expiratory flow

    Pulmonary function test using a spirometer will be performed. Peak expiratory flow will be recorded.

    Time frame: 1st day

  5. Forced mid-expiratory flow (FEF25-75)

    Pulmonary function test using a spirometer will be performed. Forced mid-expiratory flow (FEF25-75) will be recorded.

    Time frame: 1st day

  6. Physical activity level

    Physical activity will be evaluated with International Physical Activity Questionnaire questionnaire. The questionnaire assesses physical activity across different domains, including leisure time, domestic and gardening activities, work-related activities, and transport-related activities. Scores are calculated based on the duration (minutes) and frequency (days) of these activities over the past seven days. Higher scores on the IPAQ indicate a higher level of physical activity.

    Time frame: 1st day

  7. Assessment of quality of life

    St. George quality of life questionnaire will be used to assess quality of life. Higher scores reflect worse health status.

    Time frame: 1st day

  8. Activities of daily living

    Activities of daily living will be evaluated using Leicester Cough Questionnaire. Each question is scored on a scale from 1 (maximum impact) to 7 (minimal impact). An average score is calculated for each domain (physical, psychological, and social), resulting in scores ranging from 1 to 7 per domain, and a total score between 3 and 21. A higher score indicates less impact.

    Time frame: 1st day

  9. Assessment of quality of life

    Short Form-36 will be applied for assessing quality of life. Higher scores indicate better health status.

    Time frame: 1st day

07

Study locations

1 of 1 sites recruiting
  • Hacettepe University Faculty of Physical Therapy and Rehabilitation
    Ankara, Ankara 06100, Turkey (Türkiye)
    Recruiting
    • Aslihan Cakmak-Onal, PhD, PT · Contactaslihancakmak90@gmail.com · 03123051576
    • Aslihan Cakmak-Onal, PhD, PT · Principal investigator
    • Elif Kocaaga, MSc, PT · Sub investigator
    • Deniz Inal-Ince, PhD, PT · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2024 (actual). Primary completion is estimated for Jun 2027, 36 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 28, 2024
First posted
Jul 12, 2024
StartActual
Jun 15, 2024
Primary completionEst.
Jun 15, 2027
CompletionEst.
Jun 15, 2027
Last update
Jun 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06497816
Responsible party
Aslihan Cakmak-Onal (Principal Investigator, Hacettepe University) — Principal investigator
First posted
Jul 12, 2024
Start date
Jun 15, 2024
Primary completion
Jun 15, 2027 (estimated)
Completion
Jun 15, 2027 (estimated)
Last update
Jun 25, 2026

Study contacts

Aslihan Cakmak-Onal, PhD, PT
Contact
aslihancakmak90@gmail.com
03123051576 ext. 178
Elif Kocaaga, MSc, PT
Contact
elifkocaaga86@gmail.com
Aslihan Cakmak-Onal, PhD, PT
principal investigator · Hacettepe University
Deniz Inal-Ince, PhD, PT
study director · Hacettepe University
Elif Kocaaga, MSc, PT
principal investigator · Hacettepe University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion